为了提高肝癌诊断的阳性率,我们开展AFP、CEA、SF、CA19-9、CA72-4五种肿瘤标志物,对肝癌进行联合检测,探讨其在临床的意义,现将结果报告如下。 对象和方法 一、对象:100例肝癌患者(男75,女25),全部为我院住院病人,年龄18～71岁。平均54岁。均经病理、CT等确诊为原发性肝细胞肝癌。 二、方法: (一)标本收集:均取晨空腹静脉血3ml,分离 In order to improve the positive rate of liver cancer diagnosis, we carried out five tumor markers of AFP, CEA, SF, CA19-9, and CA72-4. The joint detection of liver cancer was conducted to explore its clinical significance. The results are reported below. Subjects and Methods 1. Object: 100 patients with liver cancer (male 75, female 25), all hospitalized patients in our hospital, aged 18 to 71 years old. Average 54 years old. All were diagnosed as primary hepatocellular carcinoma by pathology, CT, etc. II. Methods: (1) Specimen collection: All patients were taken 3ml of morning fasting venous blood and separated.